Studies on the Metabolic Fate of NK-104, a New Inhibitor of HMG-CoA Reductase. (3). Foeto-Placental Transfer and Mammary Excretion After Oral Administration in Rats.

Drug Metabolism and Pharmacokinetics
doi 10.2133/dmpk.13.508
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society for the Study of Xenobiotics

Related search

Studies on the Metabolic Fate of Dilevalol. (II). Absorption, Distribution, Metabolism and Excretion After Repeated Administration to Rats.

Drug Metabolism and Pharmacokinetics
1987English

Metabolic Fate of Dorzolamide, a New Carbonic Anhydrase Inhibitor. (I): Absorption, Distribution, Metabolism and Excretion of (14C)Dorzolamide After Single Administration to Rats.

Drug Metabolism and Pharmacokinetics
1995English

Studies on Poisonous Metals. X. Metabolic Fate of Manganese After Oral Administration of Excessive Manganese Chloride in Rats.

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
1983English

Metabolic Fate of Ramosetron Hydrochloride. (2). Absorption, Distribution and Excretion After Oral Administration of 14c-Ramosetron Hydrochloride to Rats.

Drug Metabolism and Pharmacokinetics
1995English

Studies on the Metabolic Fate of NZ-105. (II). Transfer Into the Fetus and Milk, and Absorption, Distribution, Metabolism and Excretion After Repeated Administration to Rats.

Drug Metabolism and Pharmacokinetics
1991English

Studies on the Metabolic Fate of Leukotriene Antagonist ONO-1078. (3). Absorption, Distribution and Excretion After Single Administration to Beagle Dogs.

Drug Metabolism and Pharmacokinetics
1993English

Metabolic Fate of Menaquinone-4 in Dogs. (I). Absorption, Distribution, Metabolism and Excretion After a Single Oral Administration.

Drug Metabolism and Pharmacokinetics
1997English

NK-104, a Newly Developed HMG-CoA Reductase Inhibitor, Suppresses Neointimal Thickening by Inhibiting Smooth Muscle Cell Growth and Fibronectin Production in Balloon-Injured Rabbit Carotid Artery.

The Japanese Journal of Pharmacology
1998English

Effects of Combined Therapy Using HMG-CoA Reductase Inhibitor and Colestimide on Refractory Hypercholesterolemia

The Journal of Japan Atherosclerosis Society
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy